TradeLink Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TradeLink Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57,900	Closed	-$4.4M	–	11
2022 Q4	$4.4M	Buy	57,900 +1,650	+3%	+$134K	94.7%	1
2022 Q3	$4.46M	Sell	56,250 -3,750	-6%	-$316K	83.28%	1
2022 Q2	$4.46M	Buy	60,000 +52,000	+650%	+$3.9M	100%	1
2022 Q1	$719K	Buy	+8,000	New	+$739K	6.04%	5
2020 Q3	–	Sell	-13,457	Closed	-$1.51M	–	54
2020 Q2	$1.51M	Buy	+13,457	New	+$1.33M	6.26%	1
2019 Q3	–	Sell	-19,100	Closed	-$1.68M	–	31
2019 Q2	$1.68M	Buy	+19,100	New	+$1.63M	25.01%	2

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TradeLink Capital's XBI Position: Q1 2023 in Review

TradeLink Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 57,900 shares — an estimated $4.4M sold.

TradeLink Capital first reported a position in XBI in Q2 2019 and held it in 6 quarters. The position peaked at $4.46M in Q3 2022. 713 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

TradeLink Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
TradeLink Capital sold 57,900 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $4.4M.
TradeLink Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and held it in 6 quarters.
TradeLink Capital's State Street SPDR S&P Biotech ETF position peaked at $4.46M in Q3 2022.
713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on TradeLink Capital's 13F filing for Q1 2023, filed 23 Jun 2023.